| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5.4M | -3.4% | +40.3% |
| SG&A Expense | $1.8M | -17.8% | +83.7% |
| Operating Income | -$7.2M | +7.5% | -49.2% |
| Pre-tax Income | -$7.4M | +5.5% | -53.2% |
| Income Tax | $2K | +0.0% | — |
| Net Income | -$7.4M | +5.5% | -53.2% |
| EPS (Basic) | -$0.11 | +21.4% | +15.4% |
| EPS (Diluted) | -$0.11 | +21.4% | +15.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.9M | -44.8% | -58.0% |
| Current Assets | $3.5M | -41.7% | -52.7% |
| Total Assets | $10.3M | -20.9% | -15.6% |
| Current Liabilities | $2.2M | -46.1% | +57.6% |
| Total Liabilities | $4.4M | +4.1% | +132.0% |
| Stockholders' Equity | $5.9M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.9M | — | — |
| Capital Expenditures | $2.9M | — | — |
| Investing Cash Flow | -$2.9M | — | — |
| Financing Cash Flow | $10.7M | — | — |
| Free Cash Flow | -$20.9M | — | — |
| -42.7% |